Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atovaquone vs SMX/TMP for Pneumocystis Carinii Pneumonia in AIDS Patients
NCT00000655Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Jan 1992
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of atovaquone in Pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
atovaquone
03
Conditions
Pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on NCT00000655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000655.